Cognito Showcases Spectris™ Alzheimer’s Trial Results at AAIC 2025
Cognito Therapeutics, a clinical-stage neurotechnology company pioneering neuromodulation-based treatments for neurodegenerative diseases, announced five new poster presentations at the Alzheimer’s Association International Conference (AAIC) 2025 supporting the clinical efficacy...